SCHEMBL7422683

SCHEMBL7422683

CNC1Cc2ccccc2C1Oc1ccc(C(C)(C)c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 5/20 0.51
SLC6A4 P31645 4/20 0.51
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
SLC9A3 P48764 8/20 0.38
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HTT P42858 1/20 0.36
SLC6A3 Q01959 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP2D6 P10635 1/20 0.36
SIGMAR1 Q99720 1/20 0.35
NR3C2 P08235 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11932029 1.00 SLC6A2 (0.51) SLC6A2SLC6A4MEN1KMT2ASLC9A3
SCHEMBL7417567 1.00 SLC6A2 (0.51) SLC6A2SLC6A4MEN1KMT2ASLC9A3
Hydrochloric Acid SCHEMBL7423941 0.99 SLC6A2 (0.50) SLC6A2SLC6A4MEN1KMT2ASLC9A3
Hydrochloric Acid SCHEMBL7423937 0.99 SLC6A2 (0.50) SLC6A2SLC6A4MEN1KMT2ASLC9A3
Hydrochloric Acid SCHEMBL7423946 0.99 SLC6A2 (0.50) SLC6A2SLC6A4MEN1KMT2ASLC9A3
SCHEMBL7419876 0.91 SLC6A2 (0.51) SLC6A2SLC6A4SLC9A3SLC6A3CYP2D6
SCHEMBL7419877 0.91 SLC6A2 (0.51) SLC6A2SLC6A4SLC9A3SLC6A3CYP2D6
SCHEMBL8639898 0.90 SLC6A2 (0.53) SLC6A2SLC6A4SLC9A3SLC6A3CYP2D6
Hydrochloric Acid SCHEMBL7408198 0.88 SLC6A2 (0.52) SLC6A2SLC6A4SLC9A3SLC6A3CYP2D6
SCHEMBL7370489 0.86 SLC6A2 (0.47) SLC6A2SLC6A4SLC9A3SLC6A3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996002494-A1 BENZOCYCLOALKYLAMINE DERIVATIVES AS CALCIUM CHANNEL ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-02-01 WO disclosed